Common use of Authorization to Use and Disclose Health Information Clause in Contracts

Authorization to Use and Disclose Health Information. Institution shall provide an appropiate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable). 8.2.

Authorization to Use and Disclose Health Information. Institution Provider shall provide an appropiate appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution Provider and Principal Investigator to provide Sponsor Sponsor, CRO and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution Provider will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable). 8.2.

Authorization to Use and Disclose Health Information. Institution shall provide an appropiate appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution will only use the authorization that is approved by SponsorSponsor or its designee, IEC and/or RA (if applicable). 8.28.1.

Authorization to Use and Disclose Health Information. Institution shall provide an appropiate appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable). 8.2.